Enrolling patients in the ongoing Phase 1b clinical trial of AKY-1189 in patients with locally advanced or mUC, breast cancer, non-small cell lung cancer, colorectal cancer, cervical cancer, and head and neck cancer

[²²⁵Ac]Ac-AKY-1189 - Aktis Oncology

May 11, 2026